基于介质细胞干细胞治疗COVID-19的主要机制

Jinling Li1,2, Shipei He1,3, Hang Yang1,3

  • 1Collaborative Innovation Centre of Regenerative Medicine and Medical BioResource Development and Application Co-Constructed by the Province and Ministry, Guangxi Key Laboratory of Regenerative Medicine and Key Laboratory of Longevity and Aging-Related Diseases of Chinese Ministry of Education, Guangxi Medical University, Shuangyong Road, Nanning, 530021, Guangxi, People's Republic of China.

概括

介质细胞干细胞疗法通过减少肺炎和损伤,显示出治疗COVID-19的前景. 对这些干细胞机制的进一步研究可以导致针对COVID-19的新治疗策略.